Objectives: To determine whether ossicular reconstruction (OCR) performed concurrent with tympanomastoidectomy for cholesteatoma results in significantly different hearing results when compared to OCR performed in a separate, staged procedure. Study Design: Retrospective. Materials and Methods: Study subjects were patients undergoing OCR within a 2-year period. Intervention was OCR concurrent with tympanomastoidectomy for cholesteatoma (group 1) or staged following tympanomastoidectomy for cholesteatoma (group 2). Main outcome measures were mean postoperative air-bone gap (ABG), proportion achieving ABG closure to <20 dB and <30 dB for group 1 and group 2 overall and when controlling for type of mastoid cavity created (open or closed) and the status of the stapes suprastructure (TORP vs. PORP OCR). Results: Eighty-three patients were identified. Forty underwent OCR concurrent with tympanomastoidectomy and 43 underwent a staged OCR after tympanomastoidectomy. Overall, similar hearing results were seen in the two groups. When considering the status of the stapes and mastoid cavity, concurrent OCR resulted in improved mean postoperative ABG in a closed mastoid cavity with an intact stapes suprastructure (P ‫؍‬ .024). Furthermore, a greater proportion of patients who had concurrent OCR within this group achieved ABG <20 dB and ABG <30 dB, although this difference did not reach statistical significance (P ‫؍‬ .092 and P ‫؍‬ .078, respectively). By contrast, staged OCR resulted in improved mean postoperative ABG and ABG <30 dB in open mastoid cavities with an absent stapes suprastructure (P ‫؍‬ .040, and P ‫؍‬ .019, respectively). Similarly, a greater proportion achieved ABG <20 dB, approaching statistical significance (P ‫؍‬ .055). Conclusions: Staged OCR is advantageous in those with most severe disease, whereas those with least severe disease may benefit from a concurrent OCR.
INTRODUCTION
The primary goal of chronic ear surgery is the production of a dry and safe ear, to stop recurrent ear drainage, and to improve hearing. To achieve these goals, Sheehy and Crabtree and Shelton and Sheehy advocated staged surgery when addressing a chronically draining ear. 1, 2 The initial surgery is to eradicate the disease (cholesteatoma and/or irreversibly diseased mucosa), create an air-containing middle ear cleft, and re-establish the integrity of the tympanic membrane. The subsequent, staged procedure is to be followed 6 to 24 months later to rule out recurrent or residual cholesteatoma and mucosal disease and to attempt the reconstitution of the ossicular chain. Improved hearing results were reported by both groups using this paradigm.
Since that time, others have advocated a single stage approach by which tympanomastoidectomy is performed concurrent with ossicular chain reconstruction. [3] [4] [5] Although residual cholesteatoma may be a concern, these authors argued against planned, staged ossicular reconstruction for all patients undergoing tympanomastoidectomy for chronic disease when only a minority will subsequently present residual or recurrent disease. Furthermore, these authors reported satisfactory hearing improvement with single stage tympanomastoidectomy and ossicular reconstruction at a frequency comparable to those reported by Crabtree and Sheehy and Sheehy and Shelton.
These studies each described the success of a single approach, whether a concurrent ossicular reconstruction was performed with tympanomastoidectomy or a staged approach was used. To our knowledge, no study has compared those two approaches within a single study population. We sought to compare the postoperative hearing results of staged ossicular reconstruction after tympanomastoidectomy with the results of ossicular reconstruction performed concurrent with tympanomastoid surgery. 
MATERIALS AND METHODS
All patients who underwent ossicular reconstruction between January 1, 2000 and June 30, 2002 were retrospectively identified at a private, tertiary referral, otology/neurotology clinic. This included patients who underwent tympanomastoidectomy with ossicular reconstruction utilizing a synthetic prosthesis for chronic otitis media and those who underwent tympanoplasty with ossicular reconstruction utilizing a synthetic prosthesis. Only those individuals with a history of a cholesteatoma in the operative ear were included. All patients had implantation of either a titanium partial ossicular replacement prosthesis (PORP) or a titanium total ossicular replacement prosthesis (TORP). Patients who had undergone ossicular reconstruction using autologous graft were excluded.
Those patients undergoing ossicular reconstruction with tympanomastoidectomy in a single stage for chronic otitis media with cholesteatoma made up group 1. The inclusion criteria for group 2 were as follows: patients who 1) underwent ossicular reconstruction with tympanoplasty and 2) had a history of a prior tympanomastoidectomy for chronic otitis media with cholesteatoma in the same ear as the one undergoing ossicular reconstruction. Those patients without a history of tympanomastoidectomy were excluded. Only those patients who underwent tympanomastoidectomy and subsequent ossicular chain reconstruction by the same surgeon (RJW or RAB) were considered. Thus, those in group 2 had at least two total procedures in exenterating cholesteatoma and reconstructing the ossicular chain. Additionally, only those patients with at least 6 months of follow-up were included in the study groups. For the purposes of this study, chronic otitis media is defined as conditions of the middle ear and mastoid that occur as a result of tubotympanic and anti-coantral pathology. Institutional review board approval of the study protocol was obtained.
The charts of patients within group 1 and group 2 were reviewed for demographic data as well as audiologic data. In particular, the age, gender, side of surgery, surgical procedure, and type of prosthesis used were noted. Audiologic data obtained on the last follow-up visit were recorded. Specifically, the average air-conduction threshold, bone-conduction threshold, and airbone gap (ABG) were recorded, considering 500, 1000, 2000, and 3000 Hz thresholds. Successful closure of the ABG to within 20 dB and to within 30 dB were noted, as well as the mean postoperative ABG following ossicular reconstruction for the groups. We also sought to consider the effects of an open or a closed mastoid cavity in the postoperative hearing results as well as the effects of a PORP ossicular reconstruction as compared to TORP ossicular reconstruction in postoperative results. Thus, the study population in group 1 and group 2 were further segregated into those with an open mastoid cavity (CWD) with either a PORP or a TORP and those with a closed mastoid cavity (CWU) with either a PORP or a TORP for comparison. The Student t test was used to determine whether the difference in mean postoperative ABG between the two groups were statistically significant, and the Fisher Exact test was used to determine whether the rates of successful closure of the ABG to within 20 dB or 30 dB were statistically significant.
RESULTS
Eighty-three patients were identified who met the inclusion criteria, and they constituted the study population. Table I displays the characteristics of the study population. Mean age was 33.9 Ϯ 19.0 years. Postoperative follow-up period ranged from 6 to 50 months, with a mean of 12.6 months. The average postoperative ABG was 22.0 dB, with 53% of subjects having an ABG less than 20 dB and 79.5% achieving a less than 30 dB ABG closure. Of patients in group 2, three individuals were found to have residual cholesteatoma at surgery to reconstruct the ossicular chain. All had closed mastoid cavities. No individuals with an open mastoid cavity within group 2 had residual cholesteatoma within the middle ear.
Overall, 40 patients made up group 1 and 43 patients made up group 2. Table II displays their characteristics. We found that the two groups achieved similar mean postoperative ABG (P ϭ .390) and similar rates of ABG closure to less than 20 dB and 30 dB (P ϭ .622 and P ϭ .433, respectively).
Review of Table II shows that those in group 1 were more likely to have an intact stapes suprastructure necessitating a PORP when compared to group 2, possibly confounding the results. To compare those individuals with similar disease severity, subgroups were identified within the 2 groups. Table III displays the resulting subgroups within groups 1 and 2 when considering the type of tympanomastoidectomy performed (open vs. closed mastoidectomies) and the synthetic ossicular prosthetic used (PORP vs. TORP).
We found that when ossicular reconstruction utilizing a TORP was staged following an open mastoid cavity procedure (CWD/TORP), a significantly improved mean postoperative ABG resulted when compared to those cases in which ossicular reconstruction was performed concurrent with the creation of an open mastoid cavity (19.1 dB vs. 30.6 dB, P ϭ .040). Likewise, closure of the ABG to less than 30 dB was significantly more frequent when ossicular reconstruction using a TORP is staged after the creation of an open mastoid cavity (87.5% vs. 37.0%, P ϭ .019). A greater proportion also had ABG closure to less than 20 dB, although this did not reach statistical significance (68.8% vs. 25.0%, P ϭ .055). Ossicular reconstruction concurrent with tympanomastoidectomy was significantly more advantageous than a staged ossicular reconstruction when considering those cases in which a PORP was used in a closed mastoid cavity (CWU/PORP, mean postoperative ABG 18.3 dB vs. 25.9 dB, P ϭ .024). A trend toward a greater proportion within group 1 achieving postoperative ABG closure to less than 20 dB and less than 30 dB was seen, but the difference was not statistically significant (62.5% vs. 30.8%, P ϭ .092 and 100% vs. 79.6%, P ϭ .078 respectively). No significant difference was seen when TORP ossicular reconstruction was performed in a closed mastoid cavity (CWU/TORP), whether it was staged after tympanomastoidectomy or performed concurrently (Table III) . Similarly, no significant difference in hearing results was seen when a PORP ossicular reconstruction was performed in an open mastoid cavity (CWD/PORP).
DISCUSSION
The conduction of sound from the ambient air to the cochlea is dependent on the surface area ratio between the tympanic membrane and the oval window and the lever mechanism of the ossicular chain. For optimal conduction, the middle ear must be air-containing, allowing maximal vibration of the tympanic membrane. Furthermore, the lever mechanism of the ossicular chain must be intact. Chronic middle ear and mastoid disease can compromise this mechanism beginning from the integrity of the tympanic membrane to the integrity of the ossicular chain itself. Additionally, the extent of the disease process may indicate the breach of an intact ossicular chain at surgery.
Earlier investigators felt that the definitive procedure to eliminate disease from the middle ear and mastoid resulted in significant mucosal denudement as to compromise the creation of an air-containing cavity. 1,2 Therefore, the ossicular prosthesis used in concurrent reconstruction of the ossicular chain is more likely to be displaced from its intended position or extruded from the middle ear. Thus, a staged approach to hearing restoration after successful disease exenteration was advocated in which an aircontaining middle ear space is ensured and the final position of the tympanic membrane has been determined from the primary procedure. Subsequent clinical series showed that comparable rates of hearing restoration could be obtained in a singlestage approach, by which the ossicular chain was reconstructed concurrently with the disease-exenterating procedure. [3] [4] [5] Previous studies examined single approaches to hearing restoration, whether ossicular reconstruction was performed concurrently with the disease exenterating surgery or in a staged manner after the primary procedure. We sought to compare the postoperative hearing results of those patients who had ossicular reconstruction concurrent with tympanomastoidectomy to those who had ossicular reconstruction staged after tympanomastoidectomy for the removal of cholesteatoma in the hands of two experienced otologic surgeons (RJW and RAB) utilizing the same ossicular prosthesis.
The decision about whether to create an open or a closed mastoid cavity and whether to perform concurrent or staged ossicular reconstruction was based on the clinical, intraoperative impression of the surgeon. In each instance, an attempt at disease exenteration was first made using an intact canal mastoidectomy. An open mastoid cavity was created in those instances in which anatomic constraints, such as lack of mastoid pneumatization, compromised safe, complete exenteration of the cholesteatoma matrix. The decision of whether to perform concurrent or staged ossicular reconstruction was based on surgeon certainty of total disease removal and the extent of mucosal denudement. Those individuals in whom the surgeon was not certain of total disease removal underwent staged ossicular reconstruction to allow for a second look at a later time, as did those with severe mucosal denudement to an extent it was felt to compromise the creation of an air-filled middle ear cleft. Gelatin film was placed over the promontory and toward the eustachian tube orifice in these cases to discourage adhesion of the tympanic membrane to the middle ear mucosa.
As a staged paradigm was adopted when total disease removal was questionable or when there was severe mucosal denudement, an inherent bias exists, with patients in group 2 likely to have had more severe disease. Although the distribution of open and closed mastoid cavities are similar in both groups, group 2 had a higher proportion without intact stapes suprastructures necessitating a TORP ossicular reconstruction, indicating more severe initial disease within this group as compared to group 1.
To minimize differences between the two study groups, we considered only those patients who had a history of a cholesteatoma and those cases in which a titanium ossicular prosthesis was used. The overall postoperative ABG as well as the rate of ABG closure to less than 20 dB in our study population is comparable to findings in previous studies. 6 -10 Furthermore, comparable postoperative hearing results were seen in the two populations in this study. To control for differences in disease severity between the two groups, we considered the role of the type of mastoid cavity created and the type of ossicular prosthetic used (TORP or PORP) on the postoperative hearing result, as these factors have been shown to influence postoperative results. [11] [12] [13] This study suffers from the weaknesses inherent with all retrospective nonrandomized studies such as unequal study groups resulting in identified and unidentified confounding factors. A randomized prospective study is most likely to yield equal groups for comparison, although the variables known to influence hearing results, such as age, severity of mucosal disease, and eustachian tube function are very difficult to control for, whether prospectively or retrospectively.
When we segregated the study population based on the status of the stapes suprastructure and the mastoid cavity, small groups resulted. Because statistical analysis of small groups are expected to yield statistically significant differences only when the results are very different between the two groups and because small statistical differences between two groups often does not translate into clinically significant differences, we feel that the analysis of the two groups based on the type of mastoid cavity created and the status of the suprastructure is valid and yields useful data.
Interestingly, we found that hearing results were better when ossicular reconstruction was performed concurrent with tympanomastoidectomy when an intact canal wall mastoid cavity (closed mastoid cavity) was created and a PORP used (CWU/PORP). By contrast, staged ossicular reconstruction yielded better hearing results when an open mastoid cavity was present and the stapes suprastructure was absent (CWD/TORP). Therefore, the decision about when to reconstruct the ossicular chain should not be uniform but should be made on a case-by-case basis depending on disease severity and the resultant anatomy after disease exenteration. Thus, patients should be counseled preoperatively about the possibility of a staged procedure based on intraoperative findings. When ossicular chain reconstruction can be performed concurrently with tympanomastoidectomy and the suspicion of residual cholesteatoma is minimal, we advocate a single-stage approach. When an open mastoid cavity is created (canal wall down mastoid cavity), ossicular reconstruction may be attempted concurrently with the mastoidectomy, but the patient should be counseled on the likelihood that a second procedure is needed for hearing restoration if the stapes suprastructure is absent.
CONCLUSION
Current techniques have allowed the establishment of an aerated middle ear cleft in the majority of patients after tympanomastoidectomy. Thus, the possibility of ossicular reconstruction concurrent with tympanomastoidectomy has been afforded. A staged approach to ossicular reconstruction after tympanomastoidectomy should be favored, with more severe disease necessitating the creation of an open mastoid cavity in an ear without an intact stapes suprastructure. In those cases in which disease severity is limited and adequate disease removal can be achieved with a closed mastoid cavity, a concurrent ossicular reconstruction should be favored.
